Printer Friendly

Danger: Counterfeit Neupogen[R] (Filgrastim).

On May 10 Amgen Inc. warned medical professionals that counterfeit vials labeled as Neupogen (filgrastim) have been found in the United States (but not in other countries at that time). These vials contain a clear liquid, but no active ingredient -- a fraud that could be life-threatening to patients.

The Amgen Web site has detailed instructions for distinguishing the counterfeit product, which is easy to do, because there are differences in the lot number, packaging, and labeling. For example, lot number P000948 is counterfeit; while lot number P000890 with one expiration date is counterfeit, but the same lot number with another expiration date is probably authentic. Since other fake labels may be printed, check the Amgen Web site, http://www.amgen.com

(Try clicking Corporate Center, then Amgen News - check the May 10 or 11 press release, which has photos showing the differences, and see if there are any later press releases.)
COPYRIGHT 2001 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:http://www.amgen.com; for information, contact Amgen Inc.; counterfeit vials labeled as Neupogen (filgrastim) found
Publication:AIDS Treatment News
Geographic Code:1USA
Date:May 25, 2001
Words:151
Previous Article:Antibodies and HIV: New Evidence Interview with Ruth Ruprecht, M.D., Ph.D.
Next Article:Danger: Counterfeit Serostim [R] (Human Growth Hormone).
Topics:


Related Articles
AMGEN WINS APPROVAL FOR NEW DRUG NEULASTA ADDS VALUE TO FIRM.
BUSINESS NOTES\Developments.
AMGEN BUYS TWO DRUGS FROM ROCHE DEAL TAPS EUROPEAN MARKET.
Counterfeit drugs: check Combivir[R], Serostim[R], Epogen[R].

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters